Nasal microbiota transplantation could revolutionise the treatment of chronic rhinosinusitis and respiratory tract infections ...

THURSDAY, Feb. 6, 2025 (HealthDay News) -- A few baseline characteristics can predict the need for recurrent endoscopic sinus ...

The probability of revision sinus surgery including removing nasal polyps is higher if the patient has asthma or is on ...

The probability of revision sinus surgery including the removal of nasal polyps is higher if the patient has asthma or is on ...

CHENGDU, China I 8, 2025 I Keymed Biosciences (HKEX: 02162) today announced the National Medical Products Administration (the "NMPA") of China has ...

Oxidative stress plays a critical role in the pathogenesis of upper and lower respiratory tract diseases, such as chronic rhinosinusitis with nasal polyps (CRSwNP), allergic rhinitis (AR), and asthma ...

According to the lawsuit, Sanofi has failed to provide partner Regeneron adequate information regarding the sales of Dupixent ...

The FDA has started a priority review of Insmed's brensocatib, which is pitching to become the first approved therapy for ...

Two former firefighters who heroically responded to the 9/11 terror attacks in New York City have died due to illnesses ...

Nasal irrigation can be a useful addition to the management of chronic upper respiratory conditions, including nasal ...

The FDA accepts and grants priority review to INSM's NDA for brensocatib to treat patients with non-cystic fibrosis bronchiectasis. A decision is due on Aug. 12, 2025.

Insmed's promising drug pipeline includes Brensocatib and Arikayce. See why INSM stock is a strong pick with multi-billion ...